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LETTERS
Hybrid El Tor 
Vibrio cholerae O1, 
Kuwait 
To the Editor: The traditional 
causative agent of cholera, Vibrio chol-
erae O1, has 2 biotypes, classical and 
El Tor. The current seventh pandemic 
that began in 1961 and has spread to 
much of the world is caused by the El 
Tor biotype. This biotype has replaced 
the classical biotype responsible for 
the previous pandemics. The classical 
and El Tor biotypes are differentiated 
by phenotypic tests (1), and several 
nucleotide base differences occur at 
positions 115 and 203 in the ctxB gene 
(C in both positions in the classical 
and T in both positions in the El Tor 
biotype). These differences translate 
to histidine at amino acid position 39 
and threonine at amino acid position 
68 for the B subunit of cholera toxin 
(CT) in the classical biotype and ty-
rosine and isoleucine, respectively, for 
the corresponding amino acids in the 
El Tor biotype (2).
Recently, 3 variants of the El Tor 
biotype have been found. These are 
the Matlab variants, which could not 
be biotyped because they have a mix-
ture of classical and El Tor traits (1); 
the Mozambique variant, which has 
a typical El Tor genome but a tandem 
repeat of the classical CTX prophage 
located in the small chromosome (3); 
and the hybrid El Tor variant, which 
has a typical El Tor biotype and an El 
Tor CTX prophage but produces CT of 
the classical type (4).
This hybrid El Tor variant has re-
placed the El Tor biotype in Dhaka and 
other parts of Bangladesh (4) and in 
India (5), Japan, Hong Kong, Zambia, 
the People’s Republic of China, Sri 
Lanka, and Vietnam (6). Kuwait was 
affected by cholera in the mid 1960s 
during the current seventh pandemic. 
Subsequently, cholera disappeared 
from Kuwait as living standards im-
proved. Screening of ≈5,000 acute-
phase diarrheal stool samples in the 
mid-1980s in a major hospital in Ku-
wait did not yield V. cholerae O1 (7). 
The occasional cholera cases detected 
in Kuwait are imported, mainly from 
Asia through expatriate workers.
Two adult men, one who had just 
arrived from India and one who had 
just arrived from the Philippines, were 
admitted with severe watery diarrhea, 
vomiting, and dehydration to the Al-
Adan Hospital, Kuwait, in November 
and December 2008, respectively. The 
patient from India reported eating in 
restaurants, and the patient from the 
Philippines had consumed ﬁ  sh  soup 
just before the journey. Both patients 
were initially rehydrated with intrave-
nous ﬂ  uids.
Stool cultures were performed by 
using a battery of media, including thio-
sulfate citrate bile salt sucrose (TCBS) 
agar. Yellow colonies from TCBS agar 
were tested by using MicroScan Walk-
Away 96 (Dade Behring, West Sac-
ramento, CA, USA) panel NBPC 34 
and API 20E strip (bioMérieux, Marcy 
l’Etoile, France), which suggested V. 
cholerae. In slide agglutination tests, 
the colonies agglutinated with V. chol-
erae O1 polyvalent antiserum and Oga-
wa serotype antiserum (Denka-Seiken, 
Tokyo, Japan). The isolate from the 
patient from India was susceptible to 
tetracycline and ampicillin and resis-
tant to co-trimoxazole, but the isolate 
from the patient from the Philippines 
was susceptible to all 3 of these anti-
microbial agents in MicroScan (Dade 
Behring) and disk diffusion tests. Both 
patients were successfully treated with 
rehydration therapy and intravenous 
vibramycin (a semisynthetic tetracy-
cline). Both V. cholerae O1 Ogawa 
isolates showed positive results in 
Vogues-Proskauer, chicken cell agglu-
tination, and tube hemolysin tests and 
were resistant to polymyxin B (50 in-
ternational units), results that suggest 
the El Tor biotype (1).
Both isolates were positive for the 
ctxA gene and El Tor–speciﬁ  c tcp gene 
but negative for classical-speciﬁ  c tcp 
gene by PCR (8). The genotype of the 
ctxB gene was determined by a mis-
match ampliﬁ   cation mutation assay 
PCR that detects polymorphism at 
nucleotide position 203; both isolates 
yielded a 186-bp amplicon with the 
classical biotype-speciﬁ  c primers and 
no amplicon with the El Tor biotype-
speciﬁ  c primers (9).
The classical ctxB genotype of 
the isolates was further conﬁ  rmed by 
sequencing the ctxB gene by using the 
BigDye termination method (Applied 
Biosystems, Foster City, CA, USA) 
with speciﬁ   c primers (10). This se-
quencing showed that both isolates had 
histidine at position 39 and threonine 
at position 68 in CT-B subunit. Thus, 
the isolates are hybrid variants that are 
phenotypically El Tor but genotypi-
cally classical for the ctxB gene. 
Our ﬁ  ndings suggest that cholera 
caused by the hybrid variant is present 
in the Philippines. The 2 cholera cases 
reported here were imported into Ku-
wait by travelers from cholera-endemic 
regions and were not endemic illnesses. 
The hybrid variant could possibly ini-
tiate the next cholera pandemic. Also, 
because CT is related to the major clini-
cal sign of the disease, genetic changes 
in the molecule could result in altera-
tion in the manifestation of the disease. 
The changes could also inﬂ  uence the 
effectiveness of cholera vaccines that 
contain CT-B as a component (6).
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